Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Tax Provisions: 2019-2025

Historic Tax Provisions for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to -$616,000.

  • Legend Biotech's Tax Provisions rose 86.11% to -$616,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year increase of 419.79%. This contributed to the annual value of $18.9 million for FY2024, which is 1094.74% up from last year.
  • Per Legend Biotech's latest filing, its Tax Provisions stood at -$616,000 for Q3 2025, which was down 5.84% from -$582,000 recorded in Q2 2025.
  • Legend Biotech's 5-year Tax Provisions high stood at $472.3 million for Q3 2022, and its period low was -$471.4 million during Q4 2022.
  • Over the past 3 years, Legend Biotech's median Tax Provisions value was -$290,000 (recorded in 2023), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Legend Biotech's Tax Provisions spiked by 1,431.41% in 2024, and later tumbled by 35,620.00% in 2025.
  • Quarterly analysis of 5 years shows Legend Biotech's Tax Provisions stood at -$3.6 million in 2021, then slumped by 12,946.64% to -$471.4 million in 2022, then skyrocketed by 99.62% to -$1.8 million in 2023, then skyrocketed by 1,431.41% to $23.6 million in 2024, then surged by 86.11% to -$616,000 in 2025.
  • Its Tax Provisions stands at -$616,000 for Q3 2025, versus -$582,000 for Q2 2025 and -$1.8 million for Q1 2025.